PD-L1 Expression in Pancreatic Cancer

J Natl Cancer Inst. 2017 Jan 28;109(6):djw304. doi: 10.1093/jnci/djw304. Print 2017 Jan.

Author

Lei Zheng¹

Affiliation

¹ Affiliations of authors: Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Graduate Program in Cellular and Molecular Medicine, Department of Surgery, The Skip Viragh Center for Pancreatic Cancer, and The Bloomberg-Kimmel Institute of Cancer Immunotherapy, The Johns Hopkins University School of Medicine, Baltimore, MD.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Antineoplastic Agents / therapeutic use*
B7-H1 Antigen / antagonists & inhibitors*
Biomarkers, Tumor / analysis*
Humans
Immunotherapy*
Pancreatic Neoplasms / diagnosis
Pancreatic Neoplasms / drug therapy*
Pancreatic Neoplasms / immunology

Substances

Antibodies, Monoclonal
Antineoplastic Agents
B7-H1 Antigen
Biomarkers, Tumor
CD274 protein, human

Grants and funding